Yeon-Hee Lim

Title: Yeon-Hee Lim: Innovator in Factor XI Activation Inhibitors

Introduction

Yeon-Hee Lim is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical conditions.

Latest Patents

Yeon-Hee Lim holds 1 patent for his invention related to Factor XI activation inhibitors. This patent provides a compound of Formula (I) and pharmaceutical compositions that include one or more of these compounds. The methods described in the patent are aimed at treating or preventing thromboses, embolisms, hypercoagulability, or fibrotic changes. The compounds developed by Lim are selective Factor XI activation inhibitors, showcasing his innovative approach to addressing critical health issues.

Career Highlights

Yeon-Hee Lim is currently employed at Merck Sharp & Dohme LLC, a leading global healthcare company. His work at Merck has allowed him to focus on groundbreaking research and development in the pharmaceutical industry. Lim's expertise and dedication have positioned him as a valuable asset in the field of medical innovation.

Collaborations

Throughout his career, Yeon-Hee Lim has collaborated with esteemed colleagues, including Jacqueline D. Hicks and Amjad Ali. These collaborations have fostered an environment of innovation and have contributed to the advancement of their shared research goals.

Conclusion

Yeon-Hee Lim's contributions to the field of pharmaceuticals, particularly through his patent on Factor XI activation inhibitors, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and showcases the importance of innovation in healthcare.